Haemonetics vs its peers
The 10 largest Health Care Supplies companies by market value, prices of Nov 20, 2026
Haemonetics is the 5th largest of the 10 biggest Health Care Supplies companies on OQRO by market value, at $5.47B. Its revenue of $1.33B in fiscal 2026 ranks 8th of 10. It keeps 12% of revenue as operating profit, 6th of 10 (median 12%). Revenue fell 2% on the year before, against a median of +3.0%. At 56.2x its latest annual earnings, the market prices it above its peers (median 39.3x).
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West Pharmaceutical ServicesWST · FY2025 | $27.2B | $3.07B | +6.3% | +7.4% | 35.9% | 19.0% | 16.1% | 15.3% | 2.4% | 55.1x | 8.8x | 1.7% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- LNTH20%
- WST19%
- COO17%
- ALGN14%
- MMSI12%
- HAE12%
- NVST8%
- ICUI2%
- NEOG−2%
Compare Haemonetics head to head
Where Haemonetics’s revenue comes from and where it goes: Haemonetics revenue breakdown. Twenty years of results: Haemonetics financial history.
Common questions
Who are Haemonetics's competitors?
The largest companies in its industry (Health Care Supplies) by market value: West Pharmaceutical Services (WST), Cooper Companies (The) (COO), Align Technology (ALGN), Lantheus Holdings (LNTH), Merit Medical Systems, Inc. (MMSI), ICU Medical (ICUI), Envista Holdings (NVST), Neogen (NEOG) and BioLife Solutions, Inc. (BLFS). They share Haemonetics's industry listing; not every one competes with it on every product.
Is Haemonetics bigger than West Pharmaceutical Services?
No, by market value: Haemonetics is worth $5.47B and West Pharmaceutical Services $27.2B. By revenue, Haemonetics brought in $1.33B in fiscal 2026 and West Pharmaceutical Services $3.07B in fiscal 2025.
Where these figures come from
The group is the companies OQRO lists in the same industry as Haemonetics (Health Care Supplies), the largest 9 by market value, plus Haemonetics. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.









